atenolol has been researched along with Pseudotumor Cerebri in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Pseudotumor Cerebri: A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury (see OPTIC NERVE DISEASES) and visual loss (see BLINDNESS).
Excerpt | Relevance | Reference |
---|---|---|
"Pseudotumor cerebri is characterized by increased intracranial pressure and papilledema, with an essentially normal neurologic examination." | 1.27 | Pseudotumor cerebri. ( Bowman, MA, 1987) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bowman, MA | 1 |
1 other study available for atenolol and Pseudotumor Cerebri
Article | Year |
---|---|
Pseudotumor cerebri.
Topics: Acetazolamide; Adult; Atenolol; Cerebrospinal Fluid Shunts; Female; Humans; Intracranial Pressure; P | 1987 |